Spotlight on: Exosome Diagnostics, first to develop RNA-based liquid biopsies

Spotlight on: Exosome Diagnostics, first to develop RNA-based liquid biopsies

Source: 
CP Wire
snippet: 

Exosome Diagnostics develops and commercializes biofluid-based cancer molecular diagnostics for patient stratification and disease monitoring. They were founded as a private company in 2008.